
Clostridium sp.
DSM 108254
Name:
"Clostridium sp."
DSM No.:
108254 dsm-108254 dsm108254 dsm 108254 Clostridium sp.
Strain designation:
H6_19
Isolated from:
human faeces
Country:
United Kingdom of Great Britain and Northern Ireland
Cambridgeshire, Hinxton
Cambridgeshire, Hinxton
Date of sampling:
11.06.2014
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; H6_19 <- H. Browne {2014}
Cultivation conditions:
Medium 339a , 37°C
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
additional information:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; H6_19 <- H. Browne {2014}. Human faeces. United Kingdom of Great Britain and Northern Ireland, Cambridgeshire, Hinxton. Taxonomy/description (30548). (Medium 339a, 37°C, anaerobic)
Literature:
Risk group:
1 (provisional classification by DSMZ)
Supplied as:
| Delivery form | Prices | ||
| Freeze Dried | 120,- € | ||
| Active culture on request | 280,- € | ||
| DNA | 180,- € | ||
| Price Category for this culture: 1 | |||
Freight and handling charges will be added. See price list.
Other cultures:
